Deconstructing FDA’s Mixed Bag Approach to Stem Cell Clinics

FDA-draft-guidance

In a nutshell, what does all of this week’s big FDA developments on stem cells and regenerative medicine mean for stem cell clinics? There’s much to be upbeat about so overall I’d say it’s good news, but I see three significant potential problems too. Dang. The good news is that the FDA seems determined to …

Deconstructing FDA’s Mixed Bag Approach to Stem Cell Clinics Read More »